Huang K X, Bergstrom D A, Ruskin D N, Walters J R
Neurophysiological Pharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
Synapse. 1998 Sep;30(1):18-29. doi: 10.1002/(SICI)1098-2396(199809)30:1<18::AID-SYN3>3.0.CO;2-N.
It has been proposed that dopamine and glutamate affect basal ganglia output, in part, through interactions between D1 receptors and NMDA receptors. The present study examined whether N-methyl-D-aspartate (NMDA) receptor antagonists affect the neurophysiological responses of substantia nigra pars compacta (SNpc; dopaminergic) and pars reticulata (SNpr; non-dopaminergic) neurons to a systemically administered D1 dopamine agonist in two animals models of Parkinson's disease, reserpine treatment and nigrostriatal lesion. Previous studies using extracellular single unit recording techniques have shown that the D1 dopamine agonist SKF 38393 (10 mg/kg) exerts different effects on the firing rates of SNpr neurons after these two dopamine-depleting treatments, suggesting the involvement of multiple mechanisms. SKF 38393 consistently increased the firing rates of SNpr neurons in rats treated subchronically with reserpine, and markedly decreased SNpr firing rates in rats with nigrostriatal damage. Pretreatment with the non-competitive NMDA antagonist MK-801 (0.15 mg/kg i.v.) blocked, and the competitive NMDA antagonist (+/-)-CPP (30 mg/kg i.p.) attenuated, the rate effects of SKF 38393 in both dopamine-depleted preparations. SKF 38393 consistently inhibited the firing rate of SNpc dopamine neurons after acute reserpine treatment (10 mg/kg, 4-7 hours), an effect specifically mediated by D1 receptors. Pretreatment with MK-801 (0.1 mg/kg i.v.) or the competitive NMDA antagonist (+)-HA-966 (30 mg/kg i.v.) also effectively attenuated SKF 38393's inhibitory effect on SNpc dopamine neurons. Therefore, NMDA receptor blockade markedly reduces the ability of D1 receptor stimulation to modulate firing rates of both dopaminergic and non-dopaminergic cells in the substantia nigra. Although multiple mechanisms appear to underlie D1-mediated effects on substantia nigra firing rates in reserpine and 6-OHDA-treated rats, these results demonstrate a common dependence on glutamatergic transmission and a permissive role for NMDA receptor activation in the ability of D1 receptor stimulation to both enhance and reduce neuronal activity in the substantia nigra.
有人提出,多巴胺和谷氨酸部分通过D1受体与NMDA受体之间的相互作用来影响基底神经节输出。本研究在两种帕金森病动物模型(利血平处理和黑质纹状体损伤)中,检验了N-甲基-D-天冬氨酸(NMDA)受体拮抗剂是否会影响黑质致密部(SNpc;多巴胺能)和黑质网状部(SNpr;非多巴胺能)神经元对系统给予的D1多巴胺激动剂的神经生理反应。以往使用细胞外单单位记录技术的研究表明,在这两种多巴胺耗竭处理后,D1多巴胺激动剂SKF 38393(10 mg/kg)对SNpr神经元的放电频率产生不同影响,提示存在多种机制。在长期接受利血平处理的大鼠中,SKF 38393持续增加SNpr神经元的放电频率,而在黑质纹状体损伤的大鼠中则显著降低SNpr的放电频率。用非竞争性NMDA拮抗剂MK-801(0.15 mg/kg静脉注射)预处理可阻断,竞争性NMDA拮抗剂(±)-CPP(30 mg/kg腹腔注射)可减弱SKF 38393在两种多巴胺耗竭制剂中的频率效应。在急性利血平处理(10 mg/kg,4 - 7小时)后,SKF 38393持续抑制SNpc多巴胺能神经元的放电频率,这一效应由D1受体特异性介导。用MK-801(0.1 mg/kg静脉注射)或竞争性NMDA拮抗剂(+)-HA-966(30 mg/kg静脉注射)预处理也可有效减弱SKF 38393对SNpc多巴胺能神经元的抑制作用。因此,NMDA受体阻断显著降低了D1受体刺激调节黑质中多巴胺能和非多巴胺能细胞放电频率的能力。尽管在利血平和6-羟基多巴胺处理的大鼠中,D1介导的对黑质放电频率的影响似乎有多种机制,但这些结果表明,在D1受体刺激增强和降低黑质神经元活动的能力方面,共同依赖于谷氨酸能传递且NMDA受体激活起允许作用。